전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article


References

  1. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu. Rev. Biochem. 67: 425-479.
    Pubmed
  2. Kerscher O, Felberbaum R, Hochstrasser M. 2006. Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu. Rev. Cell Dev. Biol. 22: 159-180.
    Pubmed
  3. Metzger MB, Hristova VA and Weissman AM. 2012. HECT and RING finger families of E3 ubiquitin ligases at a glance. J. Cell Sci. 125: 531-537.
    Pubmed PMC
  4. Deshaies RJ. 1999. SCF and Cullin/Ring H2-based ubiquitin ligases. Annu. Rev. Cell Dev. Biol. 15: 435-467.
    Pubmed
  5. Cardozo T, Pagano M. 2004. The SCF ubiquitin ligase: insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 5: 739-751.
    Pubmed
  6. Genschik P, Sumara I, Lechner E. 2013. The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications. EMBO J. 32: 2307-2320.
    Pubmed PMC
  7. Petroski MD, Deshaies RJ. 2005. Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6: 9-20.
    Pubmed
  8. Lydeard JR, Schulman BA, Harper JW. 2013. Building and remodelling Cullin-RING E3 ubiquitin ligases. EMBO Rep. 14: 10501061.
    Pubmed PMC
  9. Etienne-Manneville S, Hall A. 2002. RhoGTPases in cell biology. Nature 420: 629-635.
    Pubmed
  10. Hodge RG, Ridley AJ. 2016. Regulating Rho GTPases and their regulators. Nat. Rev. Mol. Cell Biol. 17: 496-510.
    Pubmed
  11. Schmidt A, Hall A. 2002. Guanine nucleotide exchange factors for Rho GTPases: Turning on the switch. Genes Dev. 16: 1587-1609.
    Pubmed
  12. Moon SY, Zheng Y. 2003. GTPase-activation proteins in cell regulation. Trends Cell Biol. 13: 13-22.
  13. Dovas A, Couchman JR.2005. RhoGDI: Multiple functions in the regulation of Rho family GTPase activities. Biochem. J. 390: 1-9.
    Pubmed PMC
  14. Olofsson B. 1999. guanine dissociation inhibitors: pivotal molecules in cellular signalling. Cell Signal. 11: 545-554.
  15. Dransart E, Olofsson B, Cherfils J. 2005. RhoGDIs revisited: novel roles in Rho regulation. Traffic 6: 957-966.
    Pubmed
  16. Garcia-Mata R, Boulter E, Burridge K. 2011. The ‘invisible hand’: regulation of RHO GTPases by RHOGDIs. Nat. Rev. Mol. Cell Biol. 12: 493-504.
    Pubmed PMC
  17. DerMardirossian C, Bokoch GM. 2005. GDIs: Central regulatory molecules in Rho GTPase activation. Trends Cell Biol. 15: 356-363.
    Pubmed
  18. Leonard D, Hart MJ, Platko JV, Eva A, Henzel W, Evans T, et al. 1992. The identification and characterization of a GDP-dissociation inhibitor (GDI) for the Cdc42Hs proteins. J. Biol. Chem. 267: 22860-22868.
  19. Scherle P, Behrens T, Staudt LM. 1993. Ly-GDI, a GDP-dissociation inhibitor of the RhoA GTP-binding protein, is expressed preferentially in lymphocytes. Proc. Natl. Acad. Sci. USA 90: 7568-7572.
    Pubmed PMC
  20. Adra CN, Manor D, Ko JL, Zhu S, Horiuchi T, Van Aelst L, et al. 1997. RhoGDIgamma: A GDP-dissociation inhibitor for Rho proteins with preferential expression in brain and pancreas. Proc. Natl. Acad. Sci. USA 94: 4279-4284.
    Pubmed PMC
  21. Harding MA, Theodorescu D. 2010. RhoGDI signaling provides targets for cancer therapy. Eur. J. Cancer 46: 1252-1259.
    Pubmed
  22. Cho HJ, Kim JT, Baek KE, Kim BY, Lee HG. 2019. Regulation of Rho GTPases by RhoGDIs in Human Cancers. Cells 8: 1037.
    Pubmed PMC
  23. Song Q, Xu Y, Yang C, Chen Z, Jia C, Chen J, et al. 2014 miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM. Cancer Res. 74: 3031-3042.
    Pubmed
  24. Forget MA, Desrosiers RR, Del M, Moumdjian R, Shedid D, Berthelet F, et al. 2002. The expression of rho proteins decreases with human brain tumor progression: potential tumor markers. Clin. Exp. Metastasis 19: 9-15.
    Pubmed
  25. Wang H, Wang B, Liao Q, An H, Li W, Jin X, et al. 2014. Overexpression of RhoGDI, a novel predictor of distant metastasis, promotes cell proliferation and migration in hepatocellular carcinoma. FEBS Lett. 588: 503-508.
    Pubmed
  26. Cho HJ, Kim JT, Lee SJ, Hwang YS, Park SY, Kim BY, et al. 2018. Protein phosphatase 1B dephosphorylates Rho guanine nucleotide dissociation inhibitor 1 and suppresses cancer cell migration and invasion. Cancer Lett. 417: 141-151.
    Pubmed
  27. Bayón Y, Trinidad AG, de la Puerta ML, Del Carmen Rodríguez M, Bogetz J, Rojas A, et al. 2008. KCTD5, a putative substrate adaptor for cullin3 ubiquitin ligases. FEBS J. 275: 3900-3910.
    Pubmed
  28. Brockmann M, Blomen VA, Nieuwenhuis J, Stickel E, Raaben M, Bleijerveld OB, et al. 2017. Genetic wiring maps of single-cell protein states reveal an off-switch for GPCR signalling. Nature 546: 307-311.
    Pubmed
  29. Rivas J, Díaz N, Silva I, Morales D, Lavanderos B, Álvarez A, et al. 2020. KCTD5, a novel TRPM4-regulatory protein required for cell migration as a new predictor for breast cancer prognosis. FASEB J. 34: 7847-7865.
    Pubmed
  30. Pasini S, Liu J, Corona C, Peze-Heidsieck E, Shelanski M, Greene LA. 2016. Activating Transcription Factor 4 (ATF4) modulates Rho GTPase levels and function via regulation of RhoGDIα. Sci. Rep. 6: 36952.
    Pubmed PMC
  31. Wang C, Wang X, Su Z, Fei H, Liu X, Pan Q. 2015. MiR-25 promotes hepatocellular carcinoma cell growth, migration and invasion by inhibiting RhoGDI1. Oncotarget 6: 36231-36244.
    Pubmed PMC
  32. Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M. et al. 2010. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA. Nat. Cell Biol. 12: 390-399.
    Pubmed
  33. Zhu J, Li Y, Chen C, Ma J, Sun W, Tian Z, et al. 2017. NF-κB p65 overexpression promotes bladder cancer cell migration via FBW7mediated degradation of RhoGDIα protein. Neoplasia 19: 672-683.
    Pubmed PMC
  34. Dai F, Qi Y, Guan W, Meng G, Liu Z, Zhang T, et al. 2019. RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling. Atherosclerosis 288: 124136.
    Pubmed
  35. Olson MF. 2018. GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors. Small GTPases 9: 203-215.
    Pubmed PMC
  36. Jung H, Yoon SR, Lim J, Cho HJ, Lee HG. 2020. Dysregulation of Rho GTPases in human cancers. Cancers (Basel). 12: 1179.
    Pubmed PMC
  37. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. 2005. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307: 1603-1609.
    Pubmed
  38. Chen Y, Yang Z, Meng M, Zhao Y, Dong N, Yan H, 2009. Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement. Mol Cell. 35: 841-855.
    Pubmed
  39. Kovačević I, Sakaue T, Majoleé J, Pronk MC, Maekawa M, Geerts D, et al. 2018. The Cullin-3-Rbx1-KCTD10 complex controls endothelial barrier function via K63 ubiquitination of RhoB. J. Cell Biol. 2018; 217: 1015-1032.
    Pubmed PMC

Related articles in JMB

More Related Articles